These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11385445)

  • 1. Singapore--from microprocessors to microarrays?
    Triendl R; Yoon R
    Nat Biotechnol; 2001 Jun; 19(6):521-2. PubMed ID: 11385445
    [No Abstract]   [Full Text] [Related]  

  • 2. Singapore--biotechnology development.
    Patel SH
    Clin Invest Med; 2005 Feb; 28(1):12-4. PubMed ID: 15770877
    [No Abstract]   [Full Text] [Related]  

  • 3. How the US government can fund your company.
    Basu P
    Nat Biotechnol; 2004 Apr; 22(4):482-6. PubMed ID: 15085814
    [No Abstract]   [Full Text] [Related]  

  • 4. State of the biotech sector - 2006.
    Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):706. PubMed ID: 17621283
    [No Abstract]   [Full Text] [Related]  

  • 5. Vacuum at the heart of Europe.
    Nature; 1999 Nov; 402(6757):1. PubMed ID: 10573400
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology. Singapore firm abandons plans for stem cell therapies.
    Normile D
    Science; 2007 Jul; 317(5836):305. PubMed ID: 17641170
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomedical science. Can money turn Singapore into a biotech juggernaut?
    Normile D
    Science; 2002 Aug; 297(5586):1470-3. PubMed ID: 12202801
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech marks time in Q3.
    Lawrence S
    Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech sector ponders potential 'bloodbath'.
    Mitchell P
    Nat Biotechnol; 2009 Jan; 27(1):3-4. PubMed ID: 19131974
    [No Abstract]   [Full Text] [Related]  

  • 11. Sumitomo buys Oxford finance.
    Bouchie A
    Nat Biotechnol; 2004 Apr; 22(4):480. PubMed ID: 15085808
    [No Abstract]   [Full Text] [Related]  

  • 12. Malyasian biotechnology: the valley of ghosts.
    Cyranoski D
    Nature; 2005 Aug; 436(7051):620-1. PubMed ID: 16079812
    [No Abstract]   [Full Text] [Related]  

  • 13. Ireland embraces biotechnology.
    Canning S
    Nat Biotechnol; 2000 Mar; 18(3):273-5. PubMed ID: 10700138
    [No Abstract]   [Full Text] [Related]  

  • 14. Italy: a performance review.
    Galavotti P
    Med Device Technol; 2003 Jun; 14(5):32-3. PubMed ID: 12852121
    [No Abstract]   [Full Text] [Related]  

  • 15. Portugal opens its borders to biotechnology.
    Louët S
    Nat Biotechnol; 2000 Mar; 18(3):276-7. PubMed ID: 10700139
    [No Abstract]   [Full Text] [Related]  

  • 16. Ontario--hot biotechnology in a cold climate.
    McIntyre H
    Nat Biotechnol; 2001 Jun; 19(6):523-5. PubMed ID: 11385446
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology in the Bay.
    Niiler E
    Nat Biotechnol; 2000 Mar; 18(3):280-1. PubMed ID: 10700141
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting a price on biotechnology.
    Stewart JJ; Allison PN; Johnson RS
    Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Biotech in the financial crisis.
    Jungbauer A
    Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.